darifenacin (Jubilant Cadista Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the darifenacin drug offered from Jubilant Cadista Pharmaceuticals Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Jubilant Cadista Pharmaceuticals Inc.
NON-PROPRIETARY NAME: darifenacin hydrobromide
SUBSTANCE NAME: DARIFENACIN HYDROBROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-10-12
END MARKETING DATE: 0000-00-00


darifenacin HUMAN PRESCRIPTION DRUG Details:

Item Descriptiondarifenacin from Jubilant Cadista Pharmaceuticals Inc.
LABELER NAME: Jubilant Cadista Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/1)
START MARKETING DATE: 2016-10-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59746-516_adcd4b7e-b4f5-49f3-9e39-2d126dd76a7d
PRODUCT NDC: 59746-516
APPLICATION NUMBER: ANDA205550

Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Darifenacin
Aurobindo Pharma LimitedDarifenacin
AvKARE, Inc.Darifenacin Hydrobromide
Cipla USA Inc.Darifenacin
Golden State Medical Supply, Inc.Darifenacin Hydrobromide
Jubilant Cadista Pharmaceuticals Inc.darifenacin
Macleods Pharmaceuticals LimitedDarifenacin
Par PharmaceuticalDarifenacin Hydrobromide
Torrent Pharmaceuticals LimitedDarifenacin
Warner Chilcott (US), LLCEnablex